Downloads
-
Flexible Cell Culture Media For High Titer Production Of AAV In HEK 293
2/4/2026
To maximize the results of viral titer and full capsids, it's necessary to undertake systematic process development and optimization of AAV production. The choice of cell culture medium is foundational.
-
Real-World Phase-Appropriate Control Lessons For mAb/ADC Manufacturers
2/4/2026
Effective mAb and ADC manufacturing control strategies evolve through the phases. These four principles should guide your strategy design as goals shift.
-
Made For What's Next In Drug Delivery
2/3/2026
A global partner offering prefillable drug‑delivery systems, manufacturing expertise, and integrated services that accelerate development, secure supply, and support therapies across multiple areas.
-
Engineering Reliability In Cell Therapy Manufacturing
2/3/2026
A cell therapy manufacturing model built on precision planning, digital execution, lifecycle‑ready CMC systems, and transparent collaboration to achieve high reliability and reduce variability across programs.
-
Every Detail. Built Around You.
2/3/2026
A U.S.‑based bio manufacturing campus offering end‑to‑end biologics and bioconjugation support with expert teams, scalable capacity, regulatory experience, and flexible solutions from early phase to commercial.
-
Fab Antibody Fragment Titer Improvement
2/2/2026
Learn how systematic screening of unique expression strains and plasmid combinations can overcome low protein yields, achieving active Fab titers over 4 g/L.
-
Advancing An Integrated Biopharma Workflow Strategy
1/30/2026
Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
High Specific Productivity For Leaner Sustainable Bioprocessing
1/30/2026
Improving specific productivity moves the goal beyond pumping out higher titers, but it demands a deeper understanding of cellular biology and protein expression.
-
Redefining Product Quality Through Advanced Headspace Control
1/30/2026
Nitrogen‑purging technology stabilizes vial headspace, limits oxygen exposure, protects product integrity, extends shelf life, and improves manufacturing consistency for sensitive injectables.
-
Viral Clearance Strategies For Monoclonal Antibodies And Proteins
1/30/2026
Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.